| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Connect Biopharma Holdings Ltd
13G/A
CNTB · G23549101
|
2.9% |
11/3/2026
Event 9/30/2026
|
||||
| Qiming Managing Directors Fund V, L.P. | 0.1% | |||||
| Qiming Venture Partners V, L.P. | 2.8% | |||||
| Qiming Corporate GP V, Ltd. | 2.9% | |||||
| Qiming GP V, L.P. | 2.8% | |||||
| Qiming GP VII, LLC | 1.5% | |||||
| Qiming Venture Partners VII, L.P. | 1.5% | |||||
| Qiming VII Strategic Investors Fund, L.P. | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.